Pocket Analysis
The SiteHopper PatchScore represents a summation of four Color and Shape Tanimoto coefficients weighted 3:1 in favor of Color similarity. Five pharmacophoric pseudocenter types make up the color forcefield:
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B-Raf Docking Study
An enzyme-inhibitor cocrystal structure of human B-Raf kinase with a bisamide chemotype (PDB 4G9C) [1] was prepared for modeling using Protein Preparation Wizard in Maestro. [2] To propose predicted binding modes of ligands, Glide (Grid-based Ligand Docking with Energetics) [3] was used for the docking experiments. The receptor grid was defined by a grid box of 30 × 30 × 30 Å 3 with a default inner box (10 × 10 × 10 Å 3 ) centered on the cocrystallized ligand in PDB 4G9C.
The dual pirin/B-Raf ligand compound 2 was prepared using LigPrep, [4] applying the OPLS_2005 force field with possible tautomeric and ionization states within pH range 5.0−9.0 generated. Using Glide Extra Precision (XP)
settings, flexible docking of the ligand was conducted without any constraints. The docked pose with the lowest RMSD to the bisamide-containing aromatic ring of the crystallized ligand in PDB 4G9C was selected as the predicted binding pose.
[ 
Chemistry Experimental
All final compounds were screened through our in-house computational PAINS filter and gave no structural alerts as potential assay interference compounds. Unless otherwise stated, reactions were conducted in oven dried glassware under an atmosphere of nitrogen or argon using anhydrous solvents. All commercially obtained reagents and solvents were used as received. Thin layer chromatography (TLC) was performed on pre-coated aluminum sheets of silica (60 F254 nm, Merck) and visualized using short-wave UV light. Flash column chromatography was carried out on Merck silica gel 60 (particle size 40-65 μm). Column chromatography was also performed on Biotage SP1 or Isolera 4 purification systems using Biotage Flash silica cartridges (SNAP KP-Sil). Ion exchange chromatography was performed using acidic Biotage Isolute Flash SCX-2 columns.
Semi-preparative HPLC: 500 uL standard injections (with needle wash) of the sample were made on a Phenomenex
Gemini C18 column (5μ, 250x21.2 mm, Phenomenex, Torrence, USA). Chromatographic separation at room temperature was carried out using a 1200 Series Preparative HPLC (Agilent, USA) over a 15 minutes gradient elution from 90:10 to 0:100 water:methanol (both modified with 0.1% formic acid) at a flow rate of 20 mL/min. UV-Vis spectra were acquired at 254 nm on a 1200 Series Prep Scale diode array detector (Agilent). Post-UV and pre-MS splitting was achieved using an Active Split (Agilent) before being infused into a 6120 Series Quad mass spectrometer fitted with an ESI/APCI Multimode ionization source (Agilent). Collection was triggered by UV signal and collected on a 1200 Series Fraction Collector (Agilent). 1 H-NMR spectra were recorded on Bruker Avance 500 (500 MHz) spectrometers using an internal deuterium lock. Chemical shifts are quoted in parts per million (ppm) using the 
methylphenyl)quinoline-6-carboxamide (1.0 mg, 2.0 mol) in dry DMF (0.18 mL) in the dark was added 6-amino-3-imino-9-(2-(methyl(4-oxo-4-(pyrrolidin-1-yloxy)butyl)carbamoyl)phenyl)-3H-xanthene-4,5-disulfonic acid (1.5 mg, N- (2-chloro-5-(2,3-dihydrobenzo[b] [1, 4] 
mol).and
To a solution of N- (2-chloro-5-(2,3-dihydrobenzo[b] [1, 4] 5, 165.1, 162.2, 148.7, 147.0, 143.4, 139.1, 138.0, 135.4, 131.8, 129.8, 129.3, 128.9, 128.4, 127.8, 126.7, 124.1, 122.3, 121.8, 120.3, 119.7, 117.4, 117.2, 65.4, 64.9, 64.5, 54.2, 45.8, 26.0 
Pirin Fluorescence Polarization Assay
General Information: Unless otherwise stated, the assay buffer contained 50 mM HEPES pH 7.4, 150 mM NaCl, 0.1% (w/w) CHAPS, 2% DMSO and the assay was conducted in 384 Plus F ProxiPlates (PerkinElmer). Plates were centrifuged at 1000 rpm for 1 minute prior to incubation and read using a 2103 Envision Multilabel Plate Reader.
Excitation and emission wavelengths used for green probes were 480 nm and 535 nm, respectively. Fluorescence polarization was measured in units of millipolarization (mP) and all experiments were performed in triplicate. IC 50 determination was performed using non-linear least squares curve fitting (GraphPad Prism 6, log(inhibitor) vs.
Determination of optimal probe concentration
response-variable slope (four parameters)). 
The equation states that the IC 50 for a ligand that is competitive for binding with the assay probe is related to the binding affinity of the ligand (K i ), the bound fraction of the probe (f 0 ), the binding affinity of the probe (K d ) and the concentration of the probe (L 0 ). For competition experiments, it is recommended that a protein concentration giving a bound fraction between 0.5 and 0.8 be selected. A bound fraction below 0.7 will often result in an assay that is not statistically robust due to the decreased size of the binding window, however as the bound fraction approaches 1 the relationship between K i and IC 50 deviates from linear and the resolvable range of the assay decreases. For these reasons, a bound fraction of 0.72 was used for all assays. The principal method utilized is a radioactive filter binding assay using 33 P ATP (Hastie, et al 2006 . Nat Protoc. 2006 1(2):968-71; Bain, et al 2007 . Biochem J. 2007 408(3):297-315 ). This method is sensitive, accurate and provides a direct measure of activity.
Assay step-by-step process:
1. Upon receipt of your small molecule, staff at the ICKP will dilute each to the appropriate concentration (if required)
2. This compound is added to a 'mother plate' consisting of customer samples, controls and blanks  These serve as the source for 'daughter plates' which are stored at -20* until assay initiation  Note: All compounds are screened in duplicate 3. Next there will be 3 additions to the assay:
 Enzyme-substrate mixture 1. Bar codes assigned to each file ensure that data corresponding to the correct compound is being analysed 2. After completion of each assay, ICKP staff ensure that the run has passed standard quality control measures by examining reference compounds on the QC plate 3. Upon determination that the run has met QC standards, a Z-Prime (Z') value is calculated utilizing data from the controls/blanks on each individual plate  This QC measure is in place to ensure that each individual plate in the run has passed QC 4. Finally, a mean percentage activity is calculated for for each customer.
 A standard deviation for all the duplicates is also calculated 
